Since there is an ongoing obesity epidemic, nuclear InsR, which appears to play a differential role in overweight or obese compared to normal-weight patients, warrants further investigation in an independent study, preferably in randomized clinical trials of IGF-targeting treatments. This evidence concerns the gene IGF1 and obesity disorder.